5 Ways To Choose The Right Intern
Written by Tina Samuels
There are a few tips and tricks for choosing the right intern for your company. Interns are vital members of your business team, and should be chosen with care and consideration. Don't disregard them as just temporary help.
Develop a Checklist
Make sure you know what characteristics you want your intern to have.
List them, the educational background, and the expertise you'd like to see in a checklist. Have that checklist with every interview and check off the things that the candidate has, so that when you go back to the office to consider them you can quickly scan to remember what made each candidate stand out.
Adaptation and Prioritisation
The right intern will know how to prioritise projects and tasks effectively.
While this can be learned, the right candidate will be able to grasp the concept quickly and have a knack for knowing what needs to be done. In this same vein, the right intern is adaptable and isn't rigid in the way he/she approaches tasks. This trait will help interns be able to think fast on their feet.
Match the Energy Level of the Job to Applicants
If the job the intern will do is fast paced or mentally intense, you want to hire someone that has a high energy level. In comparison, doing slower or mentally taxing jobs such as filing or file-copying will require hiring someone with relatively low energy levels. Those doing high-energy work with low energy levels will be frustrating to the company, while those doing low-energy work with high energy levels will become bored themselves.
How is Their Communication?
While they shouldn't be a Chatty Cathy, interns need to be able to speak up when needed and to effectively communicate their thoughts. In this same principle, they should be able to take constructive criticism without getting upset or becoming irate. To check for this in the interview, try open-ended questions that require more than a yes or no answer to gauge their communication level.
When you go to hire the intern, make sure they believe that there is still much to learn about their job and their ability to do the job. Those that give off warning signs of "I am an expert" and "I know everything about X" will tell you that they probably aren't going to be willing to learn, believing that they already know everything they need.
Hiring a good and trustworthy intern, even when they are merely short-term employees, helps keep your small business running smoothly and efficiently.
Always look for those star interns that you may consider for a more permanent position, too!
About the Author
Tina Samuels writes on small business topics for various websites, including ripoffreport.com.
Seo JungJin: Who is EY’s World Entrepreneur of 2021?
Seo JungJin, founder of biopharma firm Celltrion, which most recently developed an antibody treatment for COVID-19, has been named the EY World Entrepreneur of the Year 2021, becoming the first South Korean in the award’s 21-year history.
Regarded as one of the world’s most prestigious business awards program for entrepreneurs, the EY Entrepreneur of the Year celebrates visionary and innovative leaders from across 60 countries who are transforming the world and fostering growth.
JungJin, who is now honoroary chairman of Celltrion Group, was up against a worthy cast of entrepreneurial competitors, taking the crown from among 45 award winners across 38 countries and territories.
Speaking during the virtual event, JungJin described his own interpretation of entrepreneurship as something that brings together “a group of people toward a common vision, embracing challenges as opportunities and committing oneself to contribute to the greater good”.
Why was JungJin crowned King Entrepreneur?
A South Korean native and now 63 years of age, JungJin founded biopharmaceutical firm Celltrion in 2003. In the nearly two decades since its founding, Celltrion has lived up to its goal of advancing health and welfare for all by developing ground-breaking drugs to treat autoimmune disease, various forms of cancer and, most recently, COVID-19.
The company, which JungJin started with just US$45,000 and five of his colleagues, has since growth to more than 2,1000 employees with sales permits in more than 90 countries and revenues exceeding US$1.69bn.
According to the panel, JungJin’s story is a shining example of the power of an unstoppable entrepreneur to change the world with the pandel moved by both his incredible story and his purpose-driven leadership, innovative mindset and entrepreneurial spirit.
Described by the chair of the EY judging panel Rosaleen Blair as “representing everything an unstoppable should be” from taking on the world’s biggest health care challenges to consistently creating long-term value for his company, JungJin’s story is one of incredible tenacity and perseverance that the judging panel felt most represented the entrepreneurial spirit.
“He’s taken breathtaking risks, both personal and professional, to found Celltrion and grow it into one of the world’s leading biopharmaceutical companies,” says Stasia Mitchell, EY Global Entrepreneurship Leader. “His passion for creating affordable, life-saving health care and flair for tackling global problems has led to many treatments that have helped millions of people worldwide and was especially evident this past year through the creation of a COVID-19 antibody treatment.”
How did JungJin get there?
JungJin's entrepreneurial journey started at an early age when he worked as a taxi driver to get himself through Konkuk University in Seoul, South Korea. After studying industrial engineering, he rose through the ranks of Daewoo Motor Co. before losing his job amid the carmaker’s financial troubles following the 1997 Asian economic crisis.
Following this, JungJin started collaborating with colleagues to explore business opportunities in different industries, though none delivered lasting success. The turning point came after he attended a talk hosted by renowned scholars, which inspired him to focus on the biopharmaceutical sector.
And so he founded Celltrion with just US$45,000 of his savings. The launch of Remsima, credited with being the world's first antibody biosimilar, quickly moved Celltrion up the ranks of the country's fairly underdeveloped pharmaceutical sector. Celltrion followed this success with the launch of drugs for breast cancer and lymphoma that today are being used worldwide.
With ambitions to be the world’s first in different areas, Celltrion has pioneered numerous uncharted areas to great success over the past two decades, most recently responding to the global pandemic by successfully developing an antibody treatment for COVID-19 and working to ensure a timely supply of the safe and effective treatment.
“When I first started, my vision was to help patients gain access to safe, effective and affordable medicines and thereby enhance the quality of people’s lives,” explains JungJin. “The success of Celltrion has enabled me to expand on this while finding new ways to fuel my entrepreneurial drive.”